How eCOA/ePRO is transforming clinical trials
A conversation with Steve Rosenberg, CEO of uMotif electronic clinical outcome assessment (eCOA) - collecting data electronically.
AI & technology
Helen Harrington’s journey: Patience, passion, and problem-solving
From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of resilience and curiosity.
Tran Pham: Breaking barriers and building biopharma solutions
From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has built a dynamic career in biopharma.
C Ray Therapeutics raises $100 million to develop radiopharmaceuticals
The financing round will fund the improvement of the company’s technology platform for the discovery and development of innovative radionuclide drug conjugates.
Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery
Genesis also announced a further investment from NVentures, NVIDIA’s venture capital arm.
US companies enhancing decentralized clinical trials
Traditional clinical trials usually rely on several physical trial sites to recruit and monitor patients.
The decentralized clinical trials market will grow to $25 billion by 2032
Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead it to more than triple in size within the next decade.
Medable and Google Cloud partner to deliver digital clinical trials technology
The partners will work together to make Medable’s digital and decentralized clinical trial platform available on Google Cloud Marketplace.
Transparency and remote options key in clinical trial engagement
A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly highlighting how telehealth options could improve accessibility and convenience for participants.
Gifthealth and United Digestive partner for enhanced GI care access
Gifthealth Partners with United Digestive to boost patient access and procedure prep.
Jennifer Visser-Rogers: Leading science transformation at Coronado Research
In a conversation with Professor Jennifer Visser-Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical development.
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Starget Pharma’s AI-Driven Cancer Therapy Gains $5.1 Million Backing
Innovative radiotherapy offers a precision treatment alternative.
Thermo Fisher integrates Labguru ELN for streamlined lab management
Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations software.
Top 10 rare disease pharma sees 10.4% rise in therapy start
A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% increase in therapy initiation, driven by AI-enabled patient outreach and personalized communications.
Abzena’s advanced drug development showcased at CPHI Milan
At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.
GSK beefs up US manufacturing site with $800 million investment
The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, to double its size and capacity.
Rentschler Biopharma expands CDMO facilities in Germany
The expansion will involve the construction of a new buffer media facility and represents the largest investment from Rentschler at its Germany headquarters.
How Stevanato’s digital twins cut pharma manufacturing costs
Riccardo Butta, a leader at Stevanato Group, delves into how cutting-edge digital twin technology, advanced data management, and AI-driven systems are transforming manufacturing efficiency and quality in the pharmaceutical sector.
Radiopharmaceutical CDMO launched by NorthStar Medical Radioisotopes
The US manufacturer NorthStar Medical Radioisotopes has unveiled a Contract Development & Manufacturing (CDMO) facility dedicated to the production and development of medical radioisotopes.
Investors and big pharma no longer avoiding techbio companies
Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts at TechBio UK 2024, an event run by the BioIndustry Association (BIA).
Drug discovery and bringing new medicine to market - the future of AI in pharma
Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025).
From CDMOs to artificial intelligence - what's the latest in the world of outsourcing?
Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing.
SK pharmteco to strengthen small molecule and peptide capacity with $260 million investment
SK Group’s contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its small molecule and peptide manufacturing muscle in South Korea.
CPHI 2024: Stevanato to unveil large-volume injectable platform
The company, a provider of drug containment and delivery solutions, will introduce its expanded Vertiva 10mL on-body delivery system.
Ardena debuts new nanomedicines facility at CPHI 2024
At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch of a state-of-the-art nanomedicines GMP facility in Oss, Netherlands.
Symbiosis expands sterile manufacturing with new facility and innovations
As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations in sterile biopharmaceutical manufacturing.
Quotient Sciences expands with mRNA Focus at CPHI 2024
During the show, Quotient Sciences CEO Thierry Van Nieuwenhove will share insights on how the company is adapting to new FDA regulations.
CPHI Milan 2024: Enzene targets cost savings and efficiency
Enzene's monoclonal antibody production costs to dip below $40 per gram by 2025.
Authenticx CPO Eric Prugh on the impact of AI technology in pharmacovigilance
Artificial intelligence has emerged as a potential solution to inconsistent reporting of adverse events, which to this day remains one of the main challenges in the field of pharmacovigilance.
Biohaven’s real-world trial shows positive results for spinocerebellar ataxia drug
The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will now file with the FDA.
Insilico Medicine claims phase 2 win for AI-designed drug
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met its primary endpoint.
uMotif expands site and patient platform with ClinOne acquisition
uMotif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its platform with the acquisition of ClinOne, a provider of site platform solutions.
Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'
Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have confidence and answer hard questions.
How early utilisation of AI can de-risk and accelerate clinical development
Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) potential to transform drug development.
The intersection of ethics and AI in healthtech marketing: Insights from ObvioHealth
In the crowded landscape of health tech, ethical marketing has emerged as a crucial differentiator for companies striving to stand out.
Phastar's RBQM app enhances clinical trial data monitoring
Phastar have implemented an RBQM app within their Clinical Intelligence Data Visualisation Platform, enabling a comprehensive overview of the entire trial across all sites which can be shown in various visualisation graphs, tailored by client.
EnvisionOne Insights: Transforming data management in life sciences
Envision Pharma Group, a global leader in technology solutions for the life sciences industry, has unveiled its latest innovation, EnvisionOne Insights.
CluePoints sponsors RBQMLive 2024, focusing on risk-based quality management
CluePoints, the leading provider of risk-based quality management (RBQM) and data quality oversight software, has announced the full agenda and speaker line-up for the highly anticipated RBQMLive 2024.
Medidata and EORTC strengthen collaboration for oncology data management
The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata, a provider of clinical trial solutions for the life sciences industry.
Slope offering further deep, specialized expertise thanks to new services
Slope, a global provider of biospecimen lifecycle software, data, and services for clinical trials, has announced the launch of a new suite of premium services designed to optimize biospecimen operations and data management.
Creyon Bio secures second patent for AI-powered oligonucleotide engineering
Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based medicines (OBMs), recently announced the issuance of its second US patent.
AI-driven insights: SOMS boosts clinical trial success
In an in-depth conversation, OSP senior editor, Liza Laws, interviews Adrian Kizewski, associate director at IQVIA, to uncover the transformative impact of the Sub-population Optimization & Modeling Solution (SOMS) on clinical trials.
New lab software connector by LabWare and Mettler Toledo launched
LabWare Inc. and Mettler Toledo have announced a game-changing collaboration aimed at transforming laboratory productivity through a new, plug-and-play software integration.
Seqster and PatientsLikeMe partner to enhance patient data engagement
Seqster and PatientsLikeMe have announced a strategic partnership to integrate real-time electronic health record (EHR) data with patient engagement tools, aiming to significantly improve clinical research and patient outcomes.
Reimagine Care and Memorial Hermann boost cancer care engagement
Reimagine Care, the leading provider of on-demand cancer care, and Memorial Hermann Health System, one of Texas's largest not-for-profit health systems, have announced an ambitious multi-year expansion of their pioneering partnership.
Metagenomics revolution: Empress Therapeutics on drug discovery breakthroughs
Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.
New XpressGT kit speeds up diagnosis of diabetes, endometriosis and liver disease
DirectSens, an Austrian biosensor developer, has launched its latest innovation, the XpressGT RUO kit, designed for the detection of conditions related to insulin resistance, including gestational diabetes (GDM), endometriosis, and liver disease.
H1 Connect links doctors to global humanitarian missions
H1's decision to partner with GRM for this critical initiative in Ukraine was driven by a strong commitment to harness the power of global healthcare networks to provide humanitarian aid in regions that need it most.
Ayvakit's explosive 185% revenue growth: A game-changer in rare disease treatment
Ayvakit, a groundbreaking therapy developed by Blueprint Medicines, has witnessed a remarkable 185% year-over-year revenue growth in the second quarter of this year (2024).